The promise held by quantitative immunoassays to identify antibody-rich donor plasma

A new study, published in Microbiology Spectrum from the CITF-funded Canadian Blood Services (CBS) team led by Drs. Sheila O’Brien and Steven Drews, characterizes the ability of a new immunoassay to specify the concentration of neutralizing antibodies against SARS-CoV-2 in blood plasma.